Comprehensive Oncology · Immunotherapy · Surgical Oncology
Ovarian Cancer Treatment in Cuba
Ovarian cancer is often diagnosed at an advanced stage. Cuba's oncology infrastructure provides international patients with comprehensive evaluation and multidisciplinary treatment — including surgical debulking, chemotherapy, and access to immunotherapy agents such as CIMAher (nimotuzumab) for EGFR-expressing tumors. Treatment plans are determined by the medical team based on the cancer stage, histological subtype, molecular markers, and the patient's clinical condition.
Ovarian Cancer — Treatment Video
Combating Cancer in Cuba — Gynecologic Oncology
Visual Guide
Understanding ovarian cancer care in Cuba
See the specialized facilities and patient-centered care that define our ovarian cancer treatment programs.
Specialized Oncology care in Cuba
Comprehensive international patient coordination in Havana
Clinical Evidence & Outcomes
The science behind ovarian cancer treatment in Cuba
Our clinical programs are grounded in peer-reviewed research and coordinated with Cuba's biotechnology institutions. Individual results vary and are confirmed during personalized evaluation.
CIMAher® (nimotuzumab)
EGFR-Expressing Ovarian Tumors
Nimotuzumab targets the epidermal growth factor receptor (EGFR), which is expressed in a subset of ovarian tumors. It may be considered as part of a comprehensive treatment plan for eligible patients, subject to molecular testing and the treating medical team's assessment.
Source: CIM — Center of Molecular Immunology
Multidisciplinary Oncology Model
Comprehensive Ovarian Cancer Care
Ovarian cancer treatment requires a multimodal approach. Cuba's oncology infrastructure provides cytoreductive surgery, systemic chemotherapy, and access to immunotherapy. Treatment sequencing depends on stage, histological subtype, BRCA status, and the patient's overall health.
Source: SMC Salud — Office of Medical Affairs
International Patient Coordination
Comprehensive Support
SMC Salud coordinates the full international patient pathway for ovarian cancer patients, including medical record review, treatment scheduling, and post-treatment telemedicine follow-up.
Source: SMC Salud — International Patient Services
Outcomes shown reflect published clinical data and aggregate results. Individual results vary based on diagnosis, disease stage, and overall health, and are confirmed during a personalized medical evaluation. This page is for educational purposes and is not a substitute for professional medical advice.
References & Citations
Clinical content on this page is supported by peer-reviewed research and institutional publications. Individual treatment outcomes vary and are confirmed during personalized medical evaluation.
Our Comprehensive Approach
CIMAher® (nimotuzumab)
Anti-EGFR monoclonal antibody that may be considered for EGFR-expressing ovarian tumors, subject to medical evaluation.
Comprehensive Evaluation
Oncology review of imaging, biopsy, CA-125 markers, BRCA status, and prior treatments to build a personalized plan.
Multidisciplinary Tumor Board
Gynecologic oncologists, medical oncologists, radiation oncologists, and pathologists collaborate on each case.
Surgical Oncology
Access to cytoreductive surgery (debulking) including hysterectomy, oophorectomy, and omentectomy where medically appropriate.
Supportive Care
Pain management, nutritional support, psychological counseling, and survivorship programs.
International Patient Care
Full coordination: medical visa, accommodation, interpretation, and 24/7 support in Havana.
Ovarian Cancer — Treatment & Medication
Treatment Options Available in Cuba
Cuba offers comprehensive ovarian cancer treatment including cytoreductive surgery, chemotherapy, and access to CIMAher® (nimotuzumab) for EGFR-expressing tumors. Treatment is coordinated by a multidisciplinary tumor board. No therapy guarantees a cure, and not every patient will benefit. Treatment suitability is determined after medical evaluation of stage, histological subtype, BRCA status, and overall health.
Treatment suitability is determined after medical evaluation. No therapeutic outcome is guaranteed, and not every patient will benefit. Each case is reviewed individually by the medical team.
Ovarian Cancer — Required Documents
Documents for Medical Evaluation
Providing these documents helps our medical team review your case before you travel. You do not need to send every document to begin — send what you have available.
Biopsy / Pathology Report
Confirmed diagnosis and histological subtype
CT / MRI / PET-CT
Recent staging imaging
Oncology Reports
Specialist consultation and treatment notes
Previous Treatment Records
Surgery or chemotherapy history
Current Medications
All medications currently being taken
Recent Laboratory Results
Blood work and CA-125 tumor marker
Clinical Evidence
Patient Safety
Expert Specialists
International Standards
Frequently Asked Questions
Questions from international patients
Cuba offers comprehensive ovarian cancer treatment including cytoreductive surgery (debulking), chemotherapy, and access to immunotherapy agents such as CIMAher (nimotuzumab) for EGFR-expressing tumors. The specific treatment plan is determined by the medical team based on the cancer stage, histological subtype, BRCA status, and the patient's clinical condition.
Find country-specific information, testimonials, and FAQs for your region.
Could This Treatment Be Right for You?
Submit your medical records for review by our medical team. We will assess your case and provide a personalized recommendation. Treatment suitability is determined only after medical evaluation.